G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.

Exposure of peripheral blood mononuclear cells (PBMC) to an 18-base c-myb antisense oligomer before mitogen or antigen stimulation resulted in almost complete inhibition of c-myb messenger RNA and protein synthesis and blockade of T lymphocyte proliferation. Expression of early and late activation markers, interleukin-2 receptor and transferrin receptor, respectively, by PBMC was unaffected by antisense oligomer exposure as was the expression of c-myc messenger RNA. In contrast, histone H3 messenger RNA levels and DNA content were selectively decreased. These results suggest that c-myb protein deprivation does not perturb T lymphocyte activation or early molecular events that may prepare the cell for subsequent proliferation. Rather, it appears to specifically block cells in late G1 or early S phase of the cell cycle.

[1]  B. Calabretta,et al.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. , 1989, The Journal of clinical investigation.

[2]  G. Crabtree.  Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[3]  B. Calabretta,et al.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. , 1988, Science.

[4]  A. E. Sippel,et al.  Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.

[5]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[6]  P. Zamecnik,et al.  Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Wickstrom,et al.  Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[9]  E R Kandel,et al.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[11]  R. Dalla‐Favera,et al.  Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Wormington.  Stable repression of ribosomal protein L1 synthesis in Xenopus oocytes by microinjection of antisense RNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Smith,et al.  Interleukin-2 induction of T-cell G1 progression and c-myb expression. , 1986, Science.

[14]  P. Zamecnik,et al.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Nowell,et al.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Groudine,et al.  Expression of the c-myb proto-oncogene during cellular proliferation , 1986, Nature.

[17]  L. Kaczmarek,et al.  Effect of interleukin-2 on the expression of cell cycle genes in human T lymphocytes. , 1985, Biochemical and biophysical research communications.

[18]  L. Kaczmarek,et al.  Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Krensky,et al.  Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor , 1985, Nature.

[20]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[21]  P. Leder,et al.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.

[22]  L. Neckers,et al.  Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Stein,et al.  Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. , 1983, Nucleic acids research.

[24]  U. Galili,et al.  The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions. , 1976, Journal of immunology.